Thank you for subscribing!
Finfeed Archived Oct 17, 2018
The biotech sector was yesterday led by biopharmaceutical drug discovery and development company, Antisense Therapeutics (ASX:ANP) which ended the day 217% higher.
Finfeed Archived Sep 03, 2018
Prescient Therapeutics Ltd (ASX:PTX) has today advised it has identified an improved manufacturing route for PTX-100 for use in its upcoming pharmacokinetic (PK) and pharmacodynamic (PD) clinical trial.
The importance of biotech shouldn’t be underestimated, considering it can lead to tailor-made cures, eradication of diseases, better diagnostics and an overall healthier society.
Finfeed Archived Aug 30, 2018
Clinical-stage oncology company, Prescient Therapeutics (ASX:PTX), this morning updated the market on its trial of PTX-200 with cytarabine in relapsed or refractory acute myeloid leukaemia (AML).
Get expert stock analysis direct in your inbox
Join Our Mailing List
